Research reports
Where the field is
heading.
All reports
The full archive
R-006
Five years of peptide patents: what the filings reveal about the next wave of research compounds
A five-year map of peptide patent activity, treated as a signal of research investment rather than evidence of efficacy.
R-004
The GLP-1 landscape beyond semaglutide: dual and triple agonists in the research pipeline
A mechanism-by-mechanism view of dual and triple agonists, with attention to trial maturity and the limits of cross-compound comparison.